01 / Contract Profile
75F40121C00167 Federal Contract Award
Agency code 7524
EO14042 DEVELOPMENT AND MAINTENANCE OF FDA-ARGOS 2 CONTAINING REGULATORY GRADE REFERENCE GENOMES FOR DIAGNOSTIC USE AND REGULATORY SCIENCE
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75F40121C00167 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$835.0K
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2021 | $1.99M | 2 | — |
| FY 2022 | $3.43M | 2 | +72.0% |
| FY 2023 | $1.50M | 1 | −56.2% |
| FY 2024 | $2.00M | 2 | +33.1% |
| FY 2025 | $835.0K | 1 | −58.2% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION | FDA OFFICE OF ACQ GRANT SVCS |
05 / Contractor
Who holds this federal contract?
EMBLEEMA, INC.
UEI PQGTDJ2DF644 · CAGE 8KW01
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $9.75M | 8 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $9.75M | 8 | 100.0% |
08 / Place of Performance
Where is the work recorded?
SILVER SPRING, MONTGOMERY, MARYLAND, UNITED STATES
ZIP 209930001
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Sep 10, 2025 | P00007 | $835.0K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Sep 10, 2024 | P00006 | $600.0K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Jul 23, 2024 | P00005 | $1.40M | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Jul 28, 2023 | P00004 | $1.50M | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Sep 15, 2022 | P00003 | $3.43M | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Jun 2, 2022 | P00002 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Nov 18, 2021 | P00001 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
| Sep 13, 2021 | Base action | $1.99M | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541990 | AN11 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.